- Filed
- May 13, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · May 1, 2025 | 3.09M sh |
| Cash And Equivalents | Q1 2025 · Mar 31, 2025 | $5.26M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $2.63M |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $447.24K |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $737.72K |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $447.24K |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $743.17K |
| Current Assets | Q1 2025 · Mar 31, 2025 | $7.33M |
| Current Assets | Q1 2025 · Dec 31, 2024 | $9.24M |
| Total Assets | Q1 2025 · Mar 31, 2025 | $7.94M |
| Total Assets | Q1 2025 · Dec 31, 2024 | $9.84M |
| Shares Diluted restated | Q1 2025 · Mar 31, 2024 | 760.35K sh |
| Capex | Q1 2025 · Mar 31, 2024 | $32.3K |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | −$1.47M |
| Stockholders Equity | Q1 2025 · Mar 31, 2024 | $3.9M |
| Stockholders Equity | Q1 2025 · Dec 31, 2023 | $5.56M |
| Eps Diluted restated | Q1 2025 · Mar 31, 2024 | −$2.59 |
| Eps Basic restated | Q1 2025 · Mar 31, 2024 | −$2.59 |
| Sga Expense | Q1 2025 · Mar 31, 2024 | $1.11M |
| Rd Expense | Q1 2025 · Mar 31, 2024 | $216.3K |
| Net Income | Q1 2025 · Mar 31, 2024 | −$1.97M |
| Gross Profit | Q1 2025 · Mar 31, 2024 | $6.95K |
| Cost Of Revenue | Q1 2025 · Mar 31, 2024 | $376.52K |
| Revenue | Q1 2025 · Mar 31, 2024 | $383.47K |